These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4291902)

  • 1. The effects of mepyrapone (SU 4885) and some hypercholesterolaemic drugs on hepatic sterol and fatty acid oxidation.
    Dean PD; Whitehouse MW
    Biochem Pharmacol; 1967 Mar; 16(3):441-6. PubMed ID: 4291902
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of MER-29 on sterol concentration in rat tissues and on cholesterol biosynthesis in vivo and in vitro from mevalonic acid-2-C14.
    GOULD RG
    Prog Cardiovasc Dis; 1960 May; 2():492-503. PubMed ID: 13828582
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphorylation coupled to acyl-coenzyme A dehydrogenase-linked oxidation of fatty acids by liver and heart mitochondria.
    Bremer J; Davis EJ
    Biochim Biophys Acta; 1972 Sep; 275(3):298-301. PubMed ID: 5070055
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of inhibitors of sterol synthesis on growth of sordaria and phytophthora.
    Elliott CG
    J Gen Microbiol; 1969 Jun; 56(3):331-43. PubMed ID: 5793122
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion of beta sitosterol to cholesterol blocked in an insect by hypocholesterolemic agents.
    Svoboda JA; Robbins WE
    Science; 1967 Jun; 156(3782):1637-8. PubMed ID: 6025125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways of enzymic synthesis and conversion to cholesterol of delta-5,7,24-cholestatrien-3 beta-ol and other naturally occurring sterols.
    Dempsey ME
    J Biol Chem; 1965 Nov; 240(11):4176-88. PubMed ID: 4378934
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis III. Zuclomiphene in combination with AY9944 and triparanol.
    Ramsey RB
    Biochem Pharmacol; 1978; 27(12):1637-40. PubMed ID: 81057
    [No Abstract]   [Full Text] [Related]  

  • 8. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
    Illing HP; Kunke S; Netter KJ
    Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422
    [No Abstract]   [Full Text] [Related]  

  • 9. Flavoproteins of mitochondrial fatty acid oxidation.
    Garland PB; Chance B; Ernster L; Lee CP; Wong D
    Proc Natl Acad Sci U S A; 1967 Oct; 58(4):1696-702. PubMed ID: 4295832
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement and inhibition of drug metabolism.
    Anders MW
    Annu Rev Pharmacol; 1971; 11():37-56. PubMed ID: 5005155
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of hypocholesteremic compounds on bacterial multiplication.
    Aaronson S; Fulco L
    J Gen Microbiol; 1968 Feb; 50(2):271-6. PubMed ID: 5640227
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of the cellular action of drugs with protozoa. II. Comparative study of the inhibitions induced by hypocholesteremic agents on Ochromonas danica multiplication; annulment by oleic acid.
    Aaronson S; Bensky B
    J Protozool; 1965 May; 12(2):236-40. PubMed ID: 5859660
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of intestinal cholesterogenesis in vitro.
    Cayen MN; Dvornik D
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):117-20. PubMed ID: 5644629
    [No Abstract]   [Full Text] [Related]  

  • 14. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver.
    Yamada J; Ogawa S; Horie S; Watanabe T; Suga T
    Biochim Biophys Acta; 1987 Sep; 921(2):292-301. PubMed ID: 3651489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of methylglyoxal bis(guanylhydrazone) on hepatic, heart and skeletal muscle mitochondrial carnitine palmitoyltransferase and beta-oxidation of fatty acids.
    Brady LJ; Brady PS; Gandour RD
    Biochem Pharmacol; 1987 Feb; 36(4):447-52. PubMed ID: 3827937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE HYPOCHOLESTEROLEMIC ACTION OF 20,25-DIAZACHOLESTEROL.
    RANNEY RE; COOK DL
    Arch Int Pharmacodyn Ther; 1965 Mar; 154():51-62. PubMed ID: 14346416
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of Ochromonas respiration by hypocholesteremic compounds and its annulment by unsaturated fatty acids.
    Aaronson S; Roze U; Keane M; Zahalsky AC
    J Protozool; 1969 Feb; 16(1):184-6. PubMed ID: 5806194
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the effect of an inhibitor of carnitine-dependent metabolism of mildronate on the oxidation of fatty acids in the liver mitochondria of intact rats].
    Kagan TI; Simkhovich BZ; Kalvinysh IIa; Lukevits EIa
    Vopr Med Khim; 1991; 37(2):44-6. PubMed ID: 1897193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental myotonia and hypocholesterolemic agents.
    Peter JB; Dromgoole SH; Campion DS; Stempel KE; Bowman RL; Andiman RM; Nagatomo T
    Exp Neurol; 1975 Oct; 49(1 Pt 1):115-22. PubMed ID: 52555
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective biliary secretion of basal and glucagon-inhibited neutral sterol after triparanol administration.
    Meyers WC; Hanks JB; Jakoi L; Quarfordt S; Jones RS
    Surgery; 1980 Jul; 88(1):156-61. PubMed ID: 7385018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.